GlassScriptPhysician profile
William David Frazier
NPI 1700069648
$3,314.38
in general payments reported to CMS, 2019-2025
17 companies · $1,671 in 2025
The $1,671 reported for 2025 was more than what 87% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $323 · 2021: $248 · 2022: $26.03 · 2023: $314 · 2024: $199 · 2025: $1,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,286 · Food and Beverage: $862 · Consulting Fee: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,286.34 |
| Food and Beverage | $862.13 |
| Consulting Fee | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,435.01 | 2019-2025 | Inspire |
| Medtronic, INC. | $167.63 | 2024 | Stealthstation S8 Platform, Nuvent |
| Stryker Corporation | $131.48 | 2021-2025 | Ezout, Scopis Ent |
| Aerin Medical INC. | $73.75 | 2025 | |
| Glaxosmithkline, LLC. | $72.65 | 2025 | Nucala |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.34 | 2023 | Lifevest |
| Karl Storz Endoscopy-America | $54.19 | 2019 | |
| Cook Medical LLC | $49.87 | 2019 | |
| Merck Sharp & Dohme LLC | $47.02 | 2023-2025 | Keytruda |
| Intersect Ent, INC. | $44.39 | 2021-2022 | |
| Acclarent, INC | $42.21 | 2021 | |
| Smith+Nephew, INC. | $28.86 | 2019 | |
| Medtronic USA, INC. | $23.24 | 2019 | |
| Optinose US, INC. | $22.21 | 2021 | |
| Ambu INC. | $20.91 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precigen, INC. | $15.87 | 2025 | |
| Pentax of America, INC. | $15.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Frazier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.